SCHEMBL12396830

SCHEMBL12396830

C#Cc1cncc(N2CCOCC2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.47
CHRNA4 P43681 5/20 0.47
CHRNB4 P30926 5/20 0.47
CHRNA3 P32297 5/20 0.47
ADK P55263 1/20 0.45
AKR1C3 P42330 1/20 0.43
LRRK2 Q5S007 1/20 0.43
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
CHRNA1 P02708 3/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRND Q07001 1/20 0.39
CHRNA2 Q15822 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.38
CYP11B2 P19099 1/20 0.38
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30665759 1.00 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3ADK
SCHEMBL30665749 0.84 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL29108020 0.84 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL29108032 0.84 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL30665748 0.84 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL28024744 0.83 CHRNB2 (0.50) CHRNB2CHRNA4CHRNB4CHRNA3ADK
SCHEMBL30375173 0.83 CHRNB2 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL29043100 0.83 CHRNB2 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL12205229 0.82 LRRK2 (0.51) CHRNB2CHRNA4LRRK2NOS3NOS1
SCHEMBL23044774 0.80 CHRNA3 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117069650-A Alkynyl compound, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-11-17 CN disclosed
EP-2173734-B1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2016-03-23 EP disclosed
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed
WO-2009003999-A2 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 CHRNB2 4221/4885CHRNA4 4565/4885CHRNB4 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.